78 related articles for article (PubMed ID: 16381010)
21. Exposure of C6 glioma cells to Pb(II) increases the phosphorylation of p38(MAPK) and JNK1/2 but not of ERK1/2.
Posser T; de Aguiar CB; Garcez RC; Rossi FM; Oliveira CS; Trentin AG; Neto VM; Leal RB
Arch Toxicol; 2007 Jun; 81(6):407-14. PubMed ID: 17333127
[TBL] [Abstract][Full Text] [Related]
22. Early modifications in the expression of mitogen-activated protein kinase (MAPK/ERK), stress-activated kinases SAPK/JNK and p38, and their phosphorylated substrates following focal cerebral ischemia.
Ferrer I; Friguls B; Dalfó E; Planas AM
Acta Neuropathol; 2003 May; 105(5):425-37. PubMed ID: 12677442
[TBL] [Abstract][Full Text] [Related]
23. Remote vs. ischaemic preconditioning: the differential role of mitogen-activated protein kinase pathways.
Heidbreder M; Naumann A; Tempel K; Dominiak P; Dendorfer A
Cardiovasc Res; 2008 Apr; 78(1):108-15. PubMed ID: 18096574
[TBL] [Abstract][Full Text] [Related]
24. Arsenic trioxide induces apoptosis through JNK and ERK in human mesothelioma cells.
Eguchi R; Fujimori Y; Takeda H; Tabata C; Ohta T; Kuribayashi K; Fukuoka K; Nakano T
J Cell Physiol; 2011 Mar; 226(3):762-8. PubMed ID: 20799280
[TBL] [Abstract][Full Text] [Related]
25. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
26. Bcl-2 phosphorylation has pathological significance in human breast cancer.
Matsuyoshi S; Shimada K; Nakamura M; Ishida E; Konishi N
Pathobiology; 2006; 73(4):205-12. PubMed ID: 17119350
[TBL] [Abstract][Full Text] [Related]
27. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies.
Ferrer I; Blanco R; Carmona M; Puig B; Barrachina M; Gómez C; Ambrosio S
J Neural Transm (Vienna); 2001; 108(12):1383-96. PubMed ID: 11810403
[TBL] [Abstract][Full Text] [Related]
28. High nuclear phosphorylated extracellular signal-regulated kinase expression associated with poor differentiation, larger tumor size, and an advanced stage of breast cancer.
Kuo HT; Hsu HT; Chang CC; Jiang MC; Yeh CM; Shen KH; Hsu PC; Tai CJ
Pol J Pathol; 2013 Oct; 64(3):163-9. PubMed ID: 24166600
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of BRCA1 leads to increased chemoresistance to microtubule-interfering agents, an effect that involves the JNK pathway.
Lafarge S; Sylvain V; Ferrara M; Bignon YJ
Oncogene; 2001 Oct; 20(45):6597-606. PubMed ID: 11641785
[TBL] [Abstract][Full Text] [Related]
30. (-)-Epigallocatechin-3-gallate promotes pro-matrix metalloproteinase-7 production via activation of the JNK1/2 pathway in HT-29 human colorectal cancer cells.
Kim M; Murakami A; Kawabata K; Ohigashi H
Carcinogenesis; 2005 Sep; 26(9):1553-62. PubMed ID: 15860507
[TBL] [Abstract][Full Text] [Related]
31. Phosphorylated p38 and JNK MAPK proteins in hepatocellular carcinoma.
Wang SN; Lee KT; Tsai CJ; Chen YJ; Yeh YT
Eur J Clin Invest; 2012 Dec; 42(12):1295-301. PubMed ID: 23033928
[TBL] [Abstract][Full Text] [Related]
32. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.
Ferrer I; Blanco R; Carmona M; Puig B
J Neural Transm (Vienna); 2001; 108(12):1397-415. PubMed ID: 11810404
[TBL] [Abstract][Full Text] [Related]
33. [The role of Smad4 and MAPK proteins in signal transduction pathway in non-small cell lung cancer].
Tong XD; Liu HX; Zhao HR; Xu SG; Li Y; Han LB; Zhang L
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):741-5. PubMed ID: 17366784
[TBL] [Abstract][Full Text] [Related]
34. T-lymphokine-activated killer cell-originated protein kinase functions as a positive regulator of c-Jun-NH2-kinase 1 signaling and H-Ras-induced cell transformation.
Oh SM; Zhu F; Cho YY; Lee KW; Kang BS; Kim HG; Zykova T; Bode AM; Dong Z
Cancer Res; 2007 Jun; 67(11):5186-94. PubMed ID: 17545598
[TBL] [Abstract][Full Text] [Related]
35. Expression of HSP70 and JNK-related proteins in human liver cancer: Potential effects on clinical outcome.
Li H; Sui C; Kong F; Zhang H; Liu J; Dong M
Dig Liver Dis; 2007 Jul; 39(7):663-70. PubMed ID: 17531560
[TBL] [Abstract][Full Text] [Related]
36. Mitogen-activated protein kinase expression and activation does not differentiate benign from malignant mesothelial cells.
Vintman L; Nielsen S; Berner A; Reich R; Davidson B
Cancer; 2005 Jun; 103(11):2427-33. PubMed ID: 15830375
[TBL] [Abstract][Full Text] [Related]
37. The mitogen-activated protein kinases p38 and ERK1/2 are increased in lesional psoriatic skin.
Johansen C; Kragballe K; Westergaard M; Henningsen J; Kristiansen K; Iversen L
Br J Dermatol; 2005 Jan; 152(1):37-42. PubMed ID: 15656798
[TBL] [Abstract][Full Text] [Related]
38. Significantly upregulated TACSTD2 and Cyclin D1 correlate with poor prognosis of invasive ductal breast cancer.
Lin H; Huang JF; Qiu JR; Zhang HL; Tang XJ; Li H; Wang CJ; Wang ZC; Feng ZQ; Zhu J
Exp Mol Pathol; 2013 Feb; 94(1):73-8. PubMed ID: 23031786
[TBL] [Abstract][Full Text] [Related]
39. c-Jun N-terminal kinase/c-Jun inhibits fibroblast proliferation by negatively regulating the levels of stathmin/oncoprotein 18.
Yeap YY; Ng IH; Badrian B; Nguyen TV; Yip YY; Dhillon AS; Mutsaers SE; Silke J; Bogoyevitch MA; Ng DC
Biochem J; 2010 Sep; 430(2):345-54. PubMed ID: 20594188
[TBL] [Abstract][Full Text] [Related]
40. Sphinganine causes early activation of JNK and p38 MAPK and inhibition of AKT activation in HT-29 human colon cancer cells.
Ahn EH; Schroeder JJ
Anticancer Res; 2006; 26(1A):121-7. PubMed ID: 16475687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]